-
1 Comment
SunLink Health Systems, Inc is currently in a long term uptrend where the price is trading 25.5% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
SunLink Health Systems, Inc's total revenue sank by 20.7% to $10M since the same quarter in the previous year.
Its net income has increased by 7419.0% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 71.3% to $-185K since the same quarter in the previous year.
Based on the above factors, SunLink Health Systems, Inc gets an overall score of 4/5.
| Industry | Pharmaceutical Retailers |
|---|---|
| Sector | Healthcare |
| ISIN | US86737U1025 |
| CurrencyCode | USD |
| Exchange | NYSE MKT |
| Beta | 1.19 |
|---|---|
| Target Price | 2.35 |
| Dividend Yield | 0.0% |
| PE Ratio | None |
| Market Cap | 8M |
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; four clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was founded in 1959 and is based in Atlanta, Georgia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SSY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
